Oxybutynin controlled release - Beijing CoSci Med Tech
Latest Information Update: 31 Oct 2021
At a glance
- Originator Beijing CoSci Med-Tech
- Class Alkynes; Antispasmodics; Carbocyclic acids; Cyclohexanes; Diethylamines; Esters; Mandelic acids; Skin disorder therapies; Small molecules
- Mechanism of Action Cholinergic receptor antagonists; Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Generalised anxiety disorder; Panic disorder
Most Recent Events
- 28 Jul 2016 Chemical structure information added
- 26 Jul 2016 Investigation in Generalised anxiety disorder in China (PO)
- 26 Jul 2016 Investigation in Panic disorder in China (PO)